Ngian G-S, Sahhar J, Wicks I P, Van Doornum S
Department of Medicine (RMH/WH), The University of Melbourne, Parkville, Australia.
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-161-6. Epub 2014 Aug 15.
Increased arterial stiffness is a predictor of cardiovascular and all-cause mortality. Atherosclerosis may be increased in systemic sclerosis (SSc). Our aims were to determine if arterial stiffness is elevated and to evaluate correlates of arterial stiffness in SSc.
We carried out two studies: 1. a comparison of arterial stiffness in 40 SSc patients free from cardiovascular disease or significant vascular manifestations of SSc and 40 healthy controls (HC), and 2. an analysis of determinants of arterial stiffness in 80 SSc patients free from cardiovascular disease.
In Study 1, the groups were well-matched for age (52.2 vs. 50.0 years, p=0.432) and sex (80% female in both). SSc patients had higher augmentation index (AIx) than HC (31.0% [IQR 25.7-38.7] vs. 23.8% [IQR 13.5- 30.1], p<0.001). Pulse wave velocity (PWV) was also higher, however this did not reach statistical significance (6.9 m/s [IQR 6.0-8.3] vs. 6.5 m/s [IQR 6.1-7.4], p=0.275). In Study 2, age (p<0.001) and calcium channel blocker (CCB) therapy (p=0.016) were independently associated with higher AIx; and age (p<0.001), disease duration (p=0.042) and systolic blood pressure (p=0.001) with higher PWV.
SSc patients had higher AIx than HC. The paradoxical association between CCB therapy and higher AIx could reflect generalised vasculopathy rather than atherosclerotic disease. Prospective studies in larger cohorts are warranted to clarify this point and elucidate other determinants of arterial stiffness in SSc.
动脉僵硬度增加是心血管疾病和全因死亡率的预测指标。系统性硬化症(SSc)患者的动脉粥样硬化可能会加重。我们的目的是确定SSc患者的动脉僵硬度是否升高,并评估其相关因素。
我们进行了两项研究:1. 比较40例无心血管疾病或SSc显著血管表现的SSc患者与40例健康对照者(HC)的动脉僵硬度;2. 分析80例无心血管疾病的SSc患者动脉僵硬度的决定因素。
在研究1中,两组在年龄(52.2岁对50.0岁,p = 0.432)和性别(两组女性均占80%)方面匹配良好。SSc患者的增强指数(AIx)高于HC(31.0%[四分位间距25.7 - 38.7]对23.8%[四分位间距13.5 - 30.1],p < 0.001)。脉搏波速度(PWV)也较高,但未达到统计学显著性(6.9米/秒[四分位间距6.0 - 8.3]对6.5米/秒[四分位间距6.1 - 7.4],p = 0.275)。在研究2中,年龄(p < 0.001)和钙通道阻滞剂(CCB)治疗(p = 0.016)与较高的AIx独立相关;年龄(p < 0.001)、病程(p = 0.042)和收缩压(p = 0.001)与较高的PWV相关。
SSc患者的AIx高于HC。CCB治疗与较高AIx之间的矛盾关联可能反映了全身性血管病变而非动脉粥样硬化疾病。有必要在更大队列中进行前瞻性研究以阐明这一点,并阐明SSc患者动脉僵硬度的其他决定因素。